Navigation Links
CSHL scientists discover new details of a gene-regulatory network governing metabolism

Cold Spring Harbor, NY Metabolism is a central feature of life a myriad of biochemical processes that, together, enable organisms to nourish and sustain themselves. Scientists at Cold Spring Harbor Laboratory (CSHL) are in the forefront of efforts to demonstrate how the regulation of genes governs fundamental life processes, including metabolism.

Such research, performed on simple model organisms like yeast cells, has implications for efforts to understand natural processes such as aging and disease states including cancer.

This week a team at CSHL led by Professor Leemor Joshua-Tor, Ph.D., announced a new and unexpected wrinkle in a story they previously thought they understood about how yeast cells, through the action of genes, adjust their metabolism in response to changes in their sources of food. The teams findings were published February 22 in the journal Science.

Adapting to New Energy Sources

S. cerevisiae, or common bakers yeast, can use any number of different types of sugar molecules for energy production, noted Dr. Joshua-Tor, a structural biologist. Importantly, the yeast cell can rapidly respond to changes in its nutritional environment by altering the expression of specific genes that allow it to make use of those different energy sources.

This much, notes Dr. Joshua-Tor and colleagues, has been understood for years. The players involved in this process have been known for some time. But we did not understand precisely how the components of this particular biochemical pathway worked together, said Stephen Johnston, a professor at the Biodesign Institute at Arizona State University and a co-author of the study.

It was Dr. Joshua-Tors team at CSHL that took the step of investigating the architecture of the proteins involved in the pathway, at the level of individual atoms. Using a technique called x-ray crystallography, they discovered a player in the molecular cast of characters whose involvement previously had been overlooked.

The unexpected molecule is called NADP. The team discovered that when a yeast cell changes from using glucose, a simple sugar, as a nutritional source to using galactose, a more complex sugar often found in dairy products and vegetables such as sugar beets, NADP is called into action. It docks to a protein called Gal80p, which acts along with a gene regulating-protein called Gal4p, to adapt the metabolism of the yeast cell so that it can make use of galactose.

Importantly, changes in cellular levels of NAD, a close relative of NADP, had previously been linked to a gene circuit that controls aging and longevity in a large number of different organisms, including yeast but also including animals, said Professor Rolf Sternglanz of Stony Brook University in New York, a co-author of the study.

Why The Regulatory Cascade Is Important

It is becoming increasingly clear that the metabolic state of a cell is linked to the expression of its genes in a way that impacts biological processes of many kinds, ranging from cancer to aging, said Dr. Joshua-Tor. The biochemical cascade identified by the team is part of a complex chain of events whose object is regulation of the output of specific genes.

Not only does the teams work help explain how links in that gene-regulatory chain are constructed. Gene-regulatory proteins impact every property of a cell and have long been recognized as possible targets for drugs, said Dr. Joshua-Tor. However, these types of proteins have proven resistant to the chemistry of modern drug design. A detailed understanding of how gene regulatory proteins are controlled may offer new and unanticipated opportunities to design drugs that would impact this class of proteins.


Contact: Jim Bono
Cold Spring Harbor Laboratory

Related medicine news :

1. Scientists make first map of emerging-disease hotpsots
2. Scientists shed light on long-distance signaling in developing neurons
3. Scientists explore consciousness
4. Scientists using laser light to detect potential diseases via breath samples, says new study
5. Scientists move towards stem cell therapy trials to mend shattered bones
6. U-M scientists develop tool to probe role of oxidative stress in aging, disease
7. Scientists Show Stem Cells Dont Cause Cancer
8. Microbial cheaters help scientists ID social genes
9. Scientists solve structure of gene regulator that plays key role in cancer
10. VEGF Neutralization Can Damage Brain Vessels, Say Schepens Eye Research Institute Scientists
11. VEGF neutralization can damage brain vessels, say Schepens Eye Research Institute scientists
Post Your Comments:
Related Image:
CSHL scientists discover new details of a gene-regulatory network governing metabolism
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology: